A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/2004
12/15/2004	EP1485468A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
12/15/2004	EP1485391A2 Phosphate transport inhibitors
12/15/2004	EP1485379A1 Beta 3-adrenergic receptor agonists
12/15/2004	EP1485375A1 Pyrimidine compounds
12/15/2004	EP1485374A1 Pyrimidine compounds
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485356A1 NON-PEPTIDE GnRH ANTAGONISTS
12/15/2004	EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485132A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
12/15/2004	EP1485105A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
12/15/2004	EP1485104A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
12/15/2004	EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004	EP1485085A1 Phosphate prodrugs of fluorooxindoles
12/15/2004	EP1485078A1 Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
12/15/2004	EP1485073A2 Method for administration of growth hormone via pulmonary delivery
12/15/2004	EP1485068A2 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION
12/15/2004	EP1401862A4 Peptide compounds for counteracting reactive oxygen species and free radicals
12/15/2004	EP1399155A4 Small molecules useful in the treatment of inflammatory disease
12/15/2004	EP1387840B1 3,5-diamino-1,2,4-triazoles as kinase inhibitors
12/15/2004	EP1309594B1 Benzimidazole derivatives, preparation and therapeutic use thereof
12/15/2004	EP1250144B1 Vegetable oil for preparing a composition inhibiting 5$g(a)- reductase activity
12/15/2004	EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
12/15/2004	EP1226122B1 Bicyclic vasopressin agonists
12/15/2004	EP1176963B1 Use of dopamine d 3 receptor antagonists for producing medicaments for treating kidney disorders
12/15/2004	CN1555374A Novel pyridine-substituted pyrazolopyridine derivatives
12/15/2004	CN1555372A Pyrane derivatives as both ace- and nep- inhibitors
12/15/2004	CN1555356A Bisphenol derivative as NHE-3 inhibitor
12/15/2004	CN1555355A Substituted 4-aminocyclohexanol derivatives
12/15/2004	CN1555266A Hormone replacement therapy
12/15/2004	CN1554424A Strong urea nitrogen adsorbent and its preparing method
12/15/2004	CN1554415A Senshitong mixture for treating nephrolithiasis
12/15/2004	CN1554413A Chinese medicine for treating urolithiasis and its preparing method
12/15/2004	CN1554396A Yinhuang enema liquid for kindney deficiency and its preparing method
12/15/2004	CN1554365A Medicne for treating persistent recurrent non-gonococcal urethritis and its preparing method
12/15/2004	CN1554364A Process for preparing liuwei Dihuang preparation
12/15/2004	CN1554351A Medicinal composite preparation including active vitamine d compound and its use
12/15/2004	CN1554349A Dry mix formulation for bisphosphonic acids
12/15/2004	CN1179961C Sulfonamides for treatment of endothelin-mediated disorders
12/15/2004	CN1179960C Indole derivatives and their use for treamtent of osteoporosis amongst other applications
12/15/2004	CN1179958C Cyclic substituted aminomethyl compounds and medicaments containing said compounds
12/15/2004	CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them
12/15/2004	CN1179646C Aggregation-preventing nano broad spectrum antibacterial silver powder and its inductrial production process
12/14/2004	US6831186 Antiinflammatory agents; autoimmune disease
12/14/2004	US6831105 For therapy and prophylaxis of cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/14/2004	US6831091 Anticancer agents
12/14/2004	US6831082 Method of using soluble epoxide hydrolase inhibitors
12/14/2004	US6831065 Anti-inflammatory compounds and uses thereof
12/14/2004	US6831064 Enhancing clearance of fluid and urinary waste into abdominal cavity; prolonging dialysis free intervals
12/14/2004	US6831059 Compositions and methods for treating gonadotrophin related illnesses
12/12/2004	CA2465621A1 Pharmaceutical compositions of atorvastatin
12/09/2004	WO2004106938A2 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7)
12/09/2004	WO2004106935A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 103 (gpr103)
12/09/2004	WO2004106934A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)
12/09/2004	WO2004106382A1 Antibody and use thereof
12/09/2004	WO2004106312A1 Novel 2-aminoselenazoline derivative and use thereof
12/09/2004	WO2004106290A1 Amino alcohol derivatives, phamaceutical compositions containing the same, and use of both
12/09/2004	WO2004106283A1 Amino alcohol derivative, medicinal composition containing the same, and uses of these
12/09/2004	WO2004105730A1 Low sodium solution
12/09/2004	WO2004083851A3 Diagnostics and therapeutics for diseases associated with trace amine receptor 1 (ta1)
12/09/2004	WO2003097082A3 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
12/09/2004	WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence
12/09/2004	US20040250306 Transgenic rodent for use as tools in identifying modulator for treatment of diabetes, hypertension, cardiovascular and bone disorders
12/09/2004	US20040249167 Substituted benzopyrans as selective estrogen receptor-beta agonists
12/09/2004	US20040249161 Biphenyl-derivatives as p38-kinase inhibitors
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248989 Method for the treatment or prevention of lower urinary tract symptoms
12/09/2004	US20040248983 Potent analgesic and antiinflammatory effects; antiinflammatory agents; treatment of pain and inflammation; N-(3-cyclohexylphenyl)-4-hydroxy-3-methoxyphenylacetamide
12/09/2004	US20040248967 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same
12/09/2004	US20040248933 tertiary carbocyclic amines such as 4,7-diphenyl-2-methyl-1,2,3,4-tetrahydroisoquinoline, having preferential binding norepinephrine transporter protein (NET) over the other neurotransmitter transporters; side effect reduction
12/09/2004	US20040248932 Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence
12/09/2004	US20040248925 Use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence
12/09/2004	US20040248921 Reducing androgen levels; acne, prostate diseases, alopecia, hirsutism; such as 17-chloromethylene-4-aza-5-alpha-estran-3-one
12/09/2004	US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/09/2004	US20040248914 Method for the treatment of overactive bladder
12/09/2004	US20040248889 Analgesics; synthesis
12/09/2004	US20040248886 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide
12/09/2004	US20040248868 Antiischemic agents; prevent damage to tissues, organs
12/09/2004	US20040248864 Use of anthroquinones in the treatment of kidney disease
12/09/2004	US20040248817 Therapy for cardiovascular disorders; hypotensive agents; congestive heart failure
12/09/2004	US20040248771 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
12/09/2004	US20040248767 Modulating serum amyloid a interaction with tanis and agents useful for same
12/09/2004	US20040248252 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders
12/09/2004	US20040248251 Receptors and membrane associated proteins
12/09/2004	US20040248233 Using propyl hydroxylase expression system to identify modulators which interfere with or prevent generation of hypoxic states; screening modulator for treatment and prevention of cell proliferative and thrombotic disorder
12/09/2004	US20040248188 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/09/2004	US20040248178 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders
12/09/2004	US20040248088 Novel g protein-coupled receptor up-regulated in prostate cancer and uses thereof
12/09/2004	CA2820174A1 Low sodium solution for dialysis
12/09/2004	CA2524094A1 Low sodium solution
12/08/2004	EP1484320A1 Jnk inhibitor
12/08/2004	EP1483400A1 Use of the axl receptor for diagnosis and treatment of renal disease
12/08/2004	EP1483266A1 Spiro compounds with npy antagonistic activity
12/08/2004	EP1483263A1 Thiazolyl urea compounds for the treatment of cancer
12/08/2004	EP1483261A1 Phthalimide carboxylic acid derivatives
12/08/2004	EP1483260A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament

1 ... 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 ... 562